Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

China ‘gives North Korea’s Kim Jong-un and family experimental Covid vaccine’

Analyst claims jab given to leader and his close network within last three weeks

Mayank Aggarwal
Tuesday 01 December 2020 07:44 EST
Comments
Kim Jong Un riding a ski lift 
Kim Jong Un riding a ski lift  (RODONG SINMUN / EPA)

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

North Korean leader Kim Jong-un, his family and several top-ranking officials in his administration have been provided with an experimental coronavirus vaccine by China, an analyst has claimed.  

“Kim Jong-un and multiple other high-ranking officials within the Kim family and leadership network have been vaccinated for coronavirus within the last two to three weeks thanks to a vaccine candidate supplied by the Chinese government,” said Harry Kazianis, a North Korea expert who works at the Washington-based think tank Center for the National Interest.  

He revealed the information in an article on news outlet 19FortyFive, citing two unidentified Japanese intelligence sources.

But the intelligence sources did not reveal the name of the company whose experimental vaccine was administered to the North Korean leader and his officials.  

Mr Kazianis quoted scientist Dr Peter J Hotez of the Baylor College of Medicine who noted that there are “at least 3-4 different Chinese vaccines in play” including those by Sinovac Biotech Ltd, CanSinoBio and China National Pharmaceutical Group (Sinopharm).  

However, none of the three firms has shared results of the phase-III of their clinical trials.  

Experts, however, doubt that the North Korean leader would use an experimental vaccine.

Choi Jung-hun, an infectious disease expert who defected from North Korea to the South in 2012, said “even if a Chinese vaccine had already been approved, no drug is perfect and he would not take that risk when he has numerous shelters which can ensure almost complete isolation”, reported Reuters.

While East Asia analyst Mark Barry of the International Journal on World Peace said Kim would prefer proven European vaccines to the ones supplied by Beijing.  

“These Japanese sources may not realise that Kim would be loath to be provided any vital medical care by China. He would prefer a European vaccine as well as European pharmaceuticals. The risk is too great. But he's happy to get Chinese PPE (personal protective equipment),” tweeted Mr Barry.

Until now, North Korea has not confirmed any cases of coronavirus infections even as South Korea has recorded over 34,000 cases, including 500 deaths due to the pandemic.

South Korea's National Intelligence Service (NIS) has said that an outbreak of Covid-19 in North Korea cannot be ruled out as the latter had trade and people-to-people exchanges with China before it closed the borders in late January.

Microsoft had said that two North Korean hacking groups tried to break into the network of vaccine developers in multiple countries including British drugmaker AstraZeneca. The NIS recently said that it foiled North Korea's attempts to hack into South Korean COVID-19 vaccine makers.

Additional reporting by agencies

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in